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Introduction
　The Semipalatinsk Nuclear Test Site (SNTS) was con-
structed by the former Soviet Union (USSR); it was located 
in the northern Kazakhstan region. The atmospheric testing 
site was at approximately 150 km west of Semipalatinsk. 
The USSR conducted atmospheric nuclear explosions at the 
SNTS on August 29, 1949. During the nuclear weapons testing, 
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Background: From 1949 to 1989, 456 nuclear tests were conducted at the Semipalatinsk Nuclear Test Site (SNTS). Exposure 
was primarily from the first test in August 1949, an atomic bomb test in 1951, and a thermonuclear bomb test in 1953 that af-
fected the Semipalatinsk region. Surgical procedures for patients with thyroid cancer in Semipalatinsk remain unclear. As-
sessing the clinical behavior of thyroid cancer in patients affected by the SNTS is crucial for confirming an accurate diagnosis 
and establishing standardized surgery. The first author has been collaborating with the Semey Oncology Center since 1999 
to establish an optimal method to diagnose and perform thyroidectomy and lymph node dissection. 
Objective: To assess the change in the diagnostic accuracy and thyroid surgery from 1999 to 2008 at Semey Oncology Cen-
ter in collaboration with the Nagasaki University and Nagasaki Medical Center.
Materials and Methods: In this cross-sectional study, 169 patients with thyroid cancer who underwent thyroid surgery at the 
Semey Oncology Center from 1999 to 2008 were evaluated; 125 patients with papillary thyroid cancer were assessed. 
Results: Before 2001, there were few preoperatively diagnosed thyroid cancer cases; since 2002, the number of preopera-
tively diagnosed papillary cancer cases increased. From 1999 to 2001, thyroid surgery, including cervical lymph node dissec-
tion, was not performed. Partial lobectomy was mainly performed until 2001. Since 2002, total lobectomy was most com-
monly performed; total thyroidectomy and lymph node dissection were rarely performed.
Conclusion: The optimal method for diagnosing thyroid cancer was performed, and an accurate diagnosis changed the surgi-
cal procedure. 
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456 nuclear explosions were performed at this location. Of 
these 456 explosions, 88 were atmospheric and 30 were 
surface explosions. The last atmospheric test was conducted 
on December 24, 1962.1 The main contributions to the local 
and regional environmental radioactive contaminations are 
attributed to the atmospheric tests conducted on August 29, 
1949 (22 kt), September 24, 1951 (38 kt), August 12, 1953 
(400 kt), March 16, 1956 (14 kt), and August 24, 1956 (27 
kt). These tests are estimated to have contributed more than 
85% of the collective dose of the population living close to 
the SNTS.2
　Some publications which might have been influenced by 
the SNTS with respect to the incidence of several conditions, 
such as thyroid nodules and thyroid cancer.3-5 However, it is 
very difficult to evaluate the biological behavior of papillary 
carcinoma of the thyroid, which may have been affected by 
radioactive fallout, if the surgical therapies are not standard-
ized. Thyroid surgery and medical management for patients 
with papillary thyroid cancer were usually selected by patient 
assessment, such as medical care expenses, and by following 
the federal regulations for treatments. 
　Collaboration with surgeons of the Semey Oncology Center 
may change how surgery is performed for patients with 
papillary thyroid cancer. A drastic change in the treatment of 
patients with thyroid cancer may be economically and con-
ceptually difficult. Therefore, we made the system easy to use, 
in order to access the University of Nagasaki for consultations 
regarding the diagnosis. In addition, the Japanese cytology 
technician remained at the Semipalatinsk diagnostic center 
several times for 3-6 months and delivered lectures on how 
to interpret fine needle aspiration biopsies of thyroid nodules, 
as part of the JICA project.
　In these situations, we have collaborated with the Semey 
Oncology Center for thyroid surgery since 1999. The primary 
purpose of this collaboration was to improve the accuracy of 
preoperative thyroid cancer diagnosis, while the secondary 
purpose was to standardize thyroid surgery, especially the 
extent of thyroid resection. 
Materials and Methods:
　A total of 169 patients with different types of thyroid cancer 
were operated on in the Semey Oncology Center from 1999 
to 2008, and 125 patients with papillary carcinoma were 
evaluated with respect to preoperative diagnosis and surgical 
procedures in this study, according to data from the Semey 
Oncology Center. 
　Surgical collaborations such as surgical lectures and live 
demonstrations for thyroid surgery were initiated. In addition, 
multidisciplinary approaches for papillary thyroid cancer 
including nurses, consultation by radiologic technologists, 
and the Japanese surgical team of thyroid specialists, also 
demonstrated the Japanese surgical method. Every annual 
visit to the Semey Oncology Center, consultation, and lectures 
on thyroid cancer via satellite (1999-2002) or the internet 
(through 2003) have been carried out since 1999 and have 
continued for 10 years. 
　We retrospectively assessed the change in the preoperative 
accurate diagnosis rates for thyroid cancer and surgical 
procedures, such as the extent of thyroid resection. These 
medical records were obtained when we visited the Semey 
Oncology Center. 
　A paired t test was performed to compare the partial lobec-
tomy rates between 2000-2001 and 2002-2007.
Results 
　Table 1 shows the annual change in the preoperative diag-
nosis of thyroid cancer. Owing to the upgrade in the diagnostic 
accuracy of FNAB, the preoperatively diagnosed thyroid 
cancer rate has dramatically increased since 2000. 
　If thyroid cancer could be precisely diagnosed preopera-
tively, partial lobectomy was not recommended. Before 
2000, partial lobectomy was the selected operative procedure. 
In general, partial lobectomy was not recommended for 
papillary thyroid cancer, barring certain exceptions. Therefore, 
partial lobectomy rate has decreased, but lobectomy rates 
have increased since 2002 significantly. Lymph node dissection 
was infrequently indicated at the Semey Oncology Center 
(Table 2 & 3). 
Discussion 
　When surgeons from Semipalatinsk and Nagasaki began 
to collaborate in 1999, the extent of surgical resections for 
papillary thyroid cancers was small in comparison to the 
standard procedure. Preoperatively, a precise diagnosis for 
thyroid cancer was not made, since the health system infra-
structure was not adequate due to economic and technical 
insufficiencies. Even if papillary thyroid cancer was diagnosed 
preoperatively, insufficient partial lobectomy was chosen. 
Most surgical procedures for patients with papillary cancer 
consisted of a partial lobectomy without lymph node dissec-
tion. However, this may not be sufficient for the extent of 
required thyroid resection. The MACIS score was introduced 
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to indicate the prognostic factor of papillary carcinoma and 
was necessary for sufficient resection of thyroid gland.7 
However, in some economic and medical situations, difficulty 
with thyroid hormone supply might effectuate a change in the 
surgical procedure, as required in some situations. Postop-
erative recurrence rates in Semey were not clearly investigated. 
The purpose of our collaboration with the Semey Oncology 
Center was to standardize the surgical procedures for the 
thyroid operation as much as possible. Preoperative diagnoses 
for thyroid cancer have improved during the 10-year period 
that began in Semipalatinsk in 1999. In addition, surgical 
procedures have slightly changed from a partial lobectomy 
to a lobectomy.
　In general, thyroid cancer is a surgically treatable disease. 
Surgery is the most important treatment for papillary thyroid 
cancer under diagnostic accuracy.
　Optimal diagnostic methods are regularly applied nowadays. 
In addition, accurate diagnosis of thyroid cancer has led to 
changes in the surgical procedures during the study period. 
Accurate diagnosis and standardized surgical procedures 
can help evaluate the biological characteristics of thyroid 
cancer cases that may be associated with the SNTS in the 
next decade. 
Table 1. Annual change in the preoperative diagnosis of thyroid cancer. Preoperative diagnosis was made based on fine-needle aspira-
tion biopsy (FNAB) specimens. According to the diagnostic accuracy of FNAB, preoperative rates of thyroid cancer have dramatically 
increased since 2002.
Preoperative Diagnosis 2000 2001 2002 2003 2004 2005 2006 2007
Thyroid cancer (%) 1 (33) 4 (57) 16 (80) 15 (75) 19 (79) 7 (58) 8 (67) 17 (68)
Thyroid cancer (suspected) 1 1 1 2 3 3 2 4
Benign 0 2 3 1 1 1 0 3
Other disease 1 0 0 2 1 1 2 1
Total 3 7 20 20 24 12 12 25
Table 2. Partial lobectomy rate has gradually decreased. Since 2002, lobectomy rate has increased. In addition, lymph node dissection 
was infrequently indicated at the Semey Oncology Center.
Surgery Type 2000 2001 2002 2003 2004 2005 2006 2007
Partial lobectomy (%) 3 (100) 5 (71) 11 (55) 7 (35) 6 (25) 2 (17) 2 (17) 4 (16)
Lobectomy 0 0 7 9 15 9 8 15
Subtotal thyroidectomy 0 1 1 1 1 0 0 2
Total thyroidectomy 0 1 1 0 2 1 2 3
Total 3 7 20 20 24 12 12 25
+ LND 1 0 0 3 0 1 3 0
LND: Lymph node dissection
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Table 3. Comparison of surgical procedures rates between 2000-2001 and 2002-2007. Partial lobectomy rate has de-
creased, but lobectomy rate has increased significantly.
2000-2001 2002-2007
Average rate of partial lobectomy (%) 86 28 p=0.0048
Average rate of lobectomy (%) 0 58 p=0.002
Average rate of subtotal thyroidectomy (%) 7 4 NS
Average rate of total thyroidectomy (%) 7 9 NS
NS: not significant
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